semaglutide mash Significantly Improves Steatohepatitis, Fibrosis in Phase III Trial FDA Grants Accelerated Approval to

"Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis." N Engl J Med

Compounded semaglutide and tirzepatide

On the other hand, although statistical significance was not reached, the use of GLP-1RAs showed a trend towards a reduced risk of nine respiratory diseases (pneumonia, pulmonary fibrosis, dyspnea, acute respiratory failure, pleural effusion, COPD, sleep apnea syndrome, and pulmonary embolism)

The positive effects extend to cardiovascular, metabolic, and mental health, which are often overlooked when the focus is solely on the number on the scale or BMI. Other medical conditions that GLP-1 RAs may exacerbate include gastroparesis and diabetic retinopathy, Chadha noted